Document is current
Any future updates will be listed below
-
Authors
Herrmann, Goetz
Blum, Andrea
Bolliger, Daniel
Achermann, Rita
Estermann, Anna
Gebhard, Caroline Eva
Henn, Anne
Huber, Jan
Singh, Jasprit
Todorov, Atanas
Zehnder, Tatjana
Zellweger, Núria
Buser, Andreas
Tsakiris, Dimitrios A.
Hollinger, Alexa https://orcid.org/0000-0001-6799-1652
Siegemund, Martin
-
Funding
Funding for this research was provided by:
Octapharma AG (Not applicable)
- License Information
-
More Information
Article History
Received: 7 June 2021
Accepted: 22 October 2022
First Online: 20 January 2023
Declarations
:
: This study has been approved by the Ethics Committee of Northwestern and Central Switzerland in December 2020 and Swissmedic in March 2021 and will be conducted in compliance with the protocol, the current version of the Declaration of Helsinki, the ICH-GCP or ISO EN 14155 (as far as applicable) and all national legal and regulatory requirements. The study results will be presented in international conferences and published in a peer-reviewed journal.
: NA.
: Martin Siegemund, MD, has received speaker honoraria from Fresenius Kabi, Switzerland. Dimitrios Tsakiris has received speaker honoraries and unrestricted educational grants from Takeda Switzerland, CSL Behring, Octapharma, NovoNordisk. The other authors declare that they have no competing interests.
